234 related articles for article (PubMed ID: 16249071)
1. Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome.
Navone R; Lunardi C; Gerli R; Tinazzi E; Peterlana D; Bason C; Corrocher R; Puccetti A
J Autoimmun; 2005 Nov; 25(3):229-34. PubMed ID: 16249071
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
[TBL] [Abstract][Full Text] [Related]
3. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.
Fox RI; Pearson G; Vaughan JH
J Immunol; 1986 Nov; 137(10):3162-8. PubMed ID: 3021847
[TBL] [Abstract][Full Text] [Related]
4. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
5. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
6. Potential role of Epstein-Barr virus in Sjögren's syndrome.
Fox RI; Chilton T; Scott S; Benton L; Howell FV; Vaughan JH
Rheum Dis Clin North Am; 1987 Aug; 13(2):275-92. PubMed ID: 2827246
[TBL] [Abstract][Full Text] [Related]
7. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
Kahaly GJ; Bang H; Berg W; Dittmar M
Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
[TBL] [Abstract][Full Text] [Related]
9. [Possible etiological relations between Sjogren's syndrome and Epstein-Barr virus].
Yang J
Zhonghua Yi Xue Za Zhi; 1991 Mar; 71(3):131-5, 10. PubMed ID: 1648423
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
11. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
12. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
Katano K; Kawano M; Koni I; Sugai S; Muro Y
J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
[TBL] [Abstract][Full Text] [Related]
14. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
16. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
Kobayashi I; Kawamura N; Okano M; Shikano T; Mizumoto M; Hayashi Y; Kobayashi K
J Rheumatol; 2001 Feb; 28(2):363-5. PubMed ID: 11246678
[TBL] [Abstract][Full Text] [Related]
17. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
Maeno N; Takei S; Imanaka H; Oda H; Yanagi K; Hayashi Y; Miyata K
J Rheumatol; 2001 Apr; 28(4):860-4. PubMed ID: 11327263
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjögren's syndrome: difference in major epitopes between primary and secondary cases.
Shiari R; Kobayashi I; Toita N; Hatano N; Kawamura N; Okano M; Hayashi Y; Kobayashi K; Ariga T
J Rheumatol; 2006 Jul; 33(7):1395-400. PubMed ID: 16821274
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
[TBL] [Abstract][Full Text] [Related]
20. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
